Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 967.98 |
| Open | 969.27 |
| Bid | 981.84 x 100 |
| Ask | 982.77 x 100 |
| Day's Range | 966.09 - 982.66 |
| 52 Week Range | 684.81 - 998.33 |
| Volume | |
| Avg. Volume | 455,404 |
| Market Cap | 108.235B |
| Beta (5Y Monthly) | 0.17 |
| PE Ratio (TTM) | 28.98 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Sanofi (SNY), Regeneron's Dupixent sBLA Gets FDA Priority Tag
Sanofi (SNY) and Regeneron's (REGN) Dupixent is poised to be the first medicine for adolescents with inadequately controlled CRSwNP, if approved by the FDA.
- Simply Wall St.
Regeneron Pharmaceuticals, Inc.'s (NASDAQ:REGN) large institutional owners must be happy as stock continues to impress, up 3.2% over the past week
Key Insights Institutions' substantial holdings in Regeneron Pharmaceuticals implies that they have significant...
- Thomson Reuters StreetEvents
Q1 2024 Intellia Therapeutics Inc Earnings Call
Q1 2024 Intellia Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.